Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating chemotherapy with or without Rituximab in mantle cell lymphoma has completed. The update notes the trial compared outcomes with Ritux…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Chemotherapy regimen (unspecified)
• Rituxan (rituximab)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Lymphoma | Phase 2 | Status: COMPLETED